DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
SB-705498 is an investigational drug.
There have been 9 clinical trials for SB-705498. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2007.
The most common disease conditions in clinical trials are Rhinitis, Syndrome, and Irritable Bowel Syndrome. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].
Recent Clinical Trials for SB-705498
|Intranasal SB-705498 in Allergic Rhinitis (AR) Patients||GlaxoSmithKline||Phase 2|
|A Study to Investigate the Effect of SB-705498 on Chronic Cough||GlaxoSmithKline||Phase 2|
|SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis||GlaxoSmithKline||Phase 2|